Malaria remains one of the leading causes of death among children in sub-Saharan Africa, claiming more than 600,000 lives ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

Editor’s note: On September 22, 2023, a U.S. Center for Disease Control advisory board recommended that an RSV vaccine, made by Pfizer, be given between the 32nd and 36th week of pregnancy. Pregnant ...

PORTLAND, Oregon -- New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there ...

New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment. The ...

SAN DIEGO—When Ivor Royston founded his first biotech company in 1978, the 33-year-old assistant professor at the University of California, San Diego had no idea it would make him so rich ...

On 7 August 1975, Nature published a paper that has had some of the greatest impacts on science and health care in modern times. The study, by biochemists Georges Köhler and César Milstein, described ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

"Without it, I don't know how much worse I would have been," one patient said. Susan Eisen assumed her sore throat and headache would go away. Maybe she'd been working too hard, or not drinking enough ...